Skip to main navigation

Become A SpringWorker
|
Contact Us
|
LinkedIn
|
Twitter

Springworks - Investor Relations

Who We Are
Patients & Families
Pipeline
Clinical Trials
Investors & Media
Partnering
- Overview
- Our Collaborators

springworks-banner

Press Releases

Press Releases

Year

September 25, 2017

SpringWorks Therapeutics Launches with $103M in Series A Funding and Rights to Four Clinical Programs

PDF Version

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds

Springworks - Investor Relations

Who We Are

Overview
Our Values
Leadership
Board of Directors
Our Investors

Patients & Families

Overview
Desmoid Tumor
Neurofibromatosis Type 1
Expanded Access

Pipeline

Overview
Nirogacestat
Mirdametinib

Clinical Trials

Overview
DeFi Trial
ReNeu Trial

Investors & Media

Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Investor Resources

Partnering

Overview
Our Collaborators

© SpringWorks Therapeutics. All rights reserved. | Terms of Use | Privacy Policy

Become A SpringWorker
|
Contact Us
|
LinkedIn
|
Twitter